GeoVax Labs, Inc

November 22, 2013 The Wall Street Analyzer CEO Interviews Comments Off on GeoVax Labs, Inc

GeoVax Labs, Inc
(OTCQB:GOVX)
President and CEO: Robert McNally

 

THIS INTERVIEW HAS EXPIRED

About: GeoVax is a biotechnology company specializing in the creation, development, and commercialization of human vaccines to combat HIV/AIDS.

About The Wall Street Analyzer 1613 Articles
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.